Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06380517 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age

Study acronym: ATS23
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Study sites: 70 to 73v11
  2. Notable Primary completion date: Dec 1, 2026 to Jul 1, 2027
    • Study completion date: May 1, 2027 to Jan 1, 2028
    • Start date: Jul 11, 2024 to Jul 1, 2024
    v10
  3. Minor Study sites: 64 to 70v9
  4. Minor Study sites: 52 to 64v8
  5. Minor Study sites revised (52)v7
Show 5 earlier versionsHide 5 earlier versions
  1. Minor Study sites: 26 to 52v6
  2. Minor Study sites revised (26)v5
  3. Notable Phase: Not applicable to Phase 3v4
  4. Minor Study sites: 5 to 26v3
  5. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 5
    • Start date changed from estimate of May 1, 2024 to Jul 11, 2024
    v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye distance VA from randomization to 26 weeks.
Trial Details
NCT Number NCT06380517
Lead Sponsor Jaeb Center for Health Research
Collaborators: National Eye Institute (NEI), Pediatric Eye Disease Investigator Group
Conditions
(from sponsor)
Amblyopia
Related terms Amblyopia
Enrollment 238 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov